PREVALENCE, CLINICAL MANIFESTATIONS AND CO-INFECTIONS OF BURULI ULCER IN PARTS OF IMO STATE, NIGERIA

PDF

Published: 2022-02-19

Page: 356-361


CHIJIOKE J. V. ODAGHARA

Department of Biology and Microbiology, Federal Polytechnic Nekede, Owerri, Nigeria.

BERTRAM E. B. NWOKE

Department of Animal and Environmental Biology, Imo State University, Nigeria.

CHINYERE N. UKAGA

Department of Animal and Environmental Biology, Imo State University, Nigeria.

LUKE C. NWOSU *

Department of Crop and Soil Science, University of Port Harcourt, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

The study investigated prevalence, clinical manifestations and co-infections of buruli ulcer in parts of Imo State, Nigeria. The sampled human population was physically examined for buruli ulcer infection, in ulcerative stages wound swab samples were collected using sterile swab sticks and taken to the laboratory for microbial analysis. Microbial analysis of samples, gram staining, and identification of bacterial isolates, biochemical tests and determination of co-infections were achieved using standard methods. The analysis of results revealed moderately high prevalence rate of buruli ulcer disease in the area. The results further showed that in Oguta 58.54% of sampled individuals had clinical manifestations of the infection. Ohaji/Egbema recorded 51.46%, Oru East had 57.50% of victims with clinical manifestations, Onuimo had 61.29%, Isiala Mbano recorded 60.00%, Ikeduru 54.14% and Oru-West had 53.42 % of individuals with clinical manifestations of buruli ulcer. Prevalence of the buruli ulcer differed among the Local Government Areas studied. Study revealed variations in prevalence and clinical manifestations between males and females in the communities surveyed, with more females having ulcerative cases, too. Bacterial isolates confirmed from buruli ulcer disease were Staphylococcus aureus, Bacillus spp., Proteus spp., Pseudomonas aeruginosa and Streptococcus spp. Candida albicans, a fungal species was also isolated. Different microbial species responsible for pus formation in buruli ulcer wounds were highlighted. The results revealed that the toxin produced by Staphylococcus aureus caused dermatitis and toxic shock syndrome to the victims.

Keywords: Buruli ulcer infection, biochemical test, prevalence rate, bacterial isolates and toxic shock syndrome


How to Cite

ODAGHARA, C. J. V., B. NWOKE, B. E., N. UKAGA, C., & NWOSU, L. C. (2022). PREVALENCE, CLINICAL MANIFESTATIONS AND CO-INFECTIONS OF BURULI ULCER IN PARTS OF IMO STATE, NIGERIA. Asian Journal of Advances in Research, 5(1), 356–361. Retrieved from https://jasianresearch.com/index.php/AJOAIR/article/view/416

Downloads

Download data is not yet available.

References

Buntine J, Crofts K. eds. Buruli ulcer. Management of Mycobacterium ulcerans disease. A manual for health care providers. (WHO/CDS/CPE/GBUI/2001.3).Geneva: World Health Organization; 2001.

Chukwuekezie O, Ampada E, Sopoh G, Dossoi A, Tiendrebeogo A, Sadiq L, Portaels F, Asiedu K. Buruli ulcer, Nigeria. Emerging Infectious Diseases. 2007;13(5):782-783.

Asiedu K, Raviglione M, Scherpbier R. eds. Buruli ulcer: Mycobacterium ulcerans infection. (WHO/CDS/CPE/GBUI/2000.1). Geneva: World Health Organization; 2000.

Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.

Asiedu K, Raviglione M, Scherpbier R. ed. Report, International conference on Buruli ulcer control and Research Yamaissaikro, Côte d’Ivoire 6-8 July 1998. Geneva, World Health Organization, (document WHO/TB/ 98.252); 1998.

Gray HH, Kingma S, Kok SH. Mycobacterial skin ulcers in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1967;61:712-410.

Available:1016/0035-9203(67)90139-3

Porteal F. Epidemiology of mycobacterial diseases. Clinics in Dermatology. 1995;13:207-222.

Fawole MO, Oso BA. Characterization of Bacteria. In Labouratory Manual of Microbiology Spectrum Books Limited, Nigeria. 2004;22-33.

Cheesbrough M. District laboratory practice in tropical countries, Part Z, Cambridge University Press, Cambridge, UK; 2005.

Barker DJ. Buruli disease in a district of Uganda. Journal of Tropical Medicine and Hygiene. 1971;74:260–264.

Van der Werf TS, Van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet. 1999;354:1013.

World Health Organisation. Treatment of mycobacterium ulcerans disease (Buruli Ulcer): Guidance for health workers. Geneva, Switzerland: World Health Orgainisation; 2012.

World Health Orgainisation. Working to overcome the global impact of neglected tropical diseases: First WHO report on neglected tropical diseases. Geneva, Switzerland: World Health Orgainisation; 2010.